Differin AI Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

Differin holds the weakest recommendation position in the dermatologist recommended skin care brands category, with valid recommendation coverage of just 7.89% in September 2026, placing it tenth among ten tracked brands. The brand appears in only 8.95% of qualified observations, and its rank-one rate sits at 0.13%, meaning it leads recommendations in roughly one of every 760 qualified observations. Its clearest win is a modest upward movement of 1.8 points since July 2026, the second-largest gain in the category after Vanicream. The clearest opportunity lies in converting its narrow presence into stronger recommendation share within the specific acne treatment prompts where it is already surfacing.

Who This Report Is For

This report is for brand, marketing, and digital strategy leaders at Differin and within the dermatologist recommended skin care category who need to understand where AI-generated recommendations are forming and why the brand is being displaced.

Report Card

Executive Summary

Differin's presence in AI-generated recommendations for dermatologist recommended skin care is minimal. The benchmark shows the brand appearing in 68 of 760 qualified observations, a raw mention presence rate of 8.95%, and receiving valid recommendation credit in only 60 of those observations. This places Differin at the bottom of the category, far behind category leader CeraVe at 91.18% coverage and even behind ninth-place Eucerin at 26.71%.

The brand's mention profile is almost entirely positive. Of 68 total mentions, 62 were positive, 5 were neutral, and 1 was negative, producing a net sentiment score of 0.8971. This suggests that when AI systems do reference Differin, they frame it constructively. The problem is not negative framing; it is the near-total absence of the brand from recommendation shortlists.

Differin's strongest signal is its upward movement. Valid recommendation coverage rose from 6.1% in July 2026 to 7.9% in September 2026, a gain of 1.8 points. While the absolute numbers remain small, this was the second-largest coverage increase in the category after Vanicream's 6.1-point rise. The movement suggests some prompt patterns are beginning to surface the brand more consistently.

The weakest signal is recommendation placement. Differin's top-three rate is 1.84%, and its rank-one rate is 0.13%. The brand received a rank-one recommendation in only 1 of 760 qualified observations. When Differin is recommended, its average rank is 4.70, meaning it typically appears near the bottom of any shortlist.

Platform performance is consistently weak across all six tracked surfaces. ChatGPT shows the highest positive visibility rate at 9.30%, while Google AI Mode shows the lowest at 6.06%. No platform emerges as a meaningful recommendation engine for Differin.

The category context matters. CeraVe and La Roche-Posay dominate the top of the market, while Vanicream is rising rapidly. The significant decliners, Aveeno, Eucerin, and Neutrogena, are losing presence and coverage. Differin's small base means its movements are less stable than larger brands, and percentage changes should be interpreted with caution.

What Differin Is Winning

Questions This Section Answers

• What evidence-backed wins does Differin have in this benchmark?
• How did Differin's recommendation coverage move between July and September 2026?

Differin has few evidence-backed wins in this benchmark, and they should be stated plainly.

The clearest win is momentum. Differin's valid recommendation coverage rose from 6.1% in July 2026 to 7.9% in September 2026, a gain of 1.8 points. This was the second-largest increase in the category over the tracking period. The movement is small in absolute terms, but it is directionally positive in a month where three brands declined significantly.

The brand also maintains a strongly positive framing profile. With 62 positive mentions out of 68 total, Differin's net sentiment score of 0.8971 is the highest among the bottom five brands. When AI systems mention Differin, they do so favorably. The single negative mention in the dataset is an outlier rather than a pattern.

Differin's presence is narrow but real. The brand appears in 68 qualified observations, which means it is not entirely absent from AI-generated skin care recommendations. The challenge is that this presence rarely converts into a recommendation position that a shopper would act on.

Where Differin Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Differin's AI presence fail to convert into top-three or rank-one recommendations?
• How does Differin's placement compare with category leaders like CeraVe and La Roche-Posay?
• What does the absence of comparison-stage and pricing-stage data mean for Differin?

Differin's core problem is visibility without recommendation conversion. The brand is mentioned in 68 observations but recommended in only 60, and recommended in the top three in only 14. This means the vast majority of Differin mentions do not translate into a shortlist position that matters.

The gap between presence and recommendation strength is stark. Differin's presence rate of 8.95% is nearly identical to its valid recommendation coverage of 7.89%, suggesting that when the brand appears, it is usually recommended. But the recommendation is almost always buried. The top-three rate of 1.84% and rank-one rate of 0.13% show that Differin rarely leads or even appears prominently in any answer.

Platform displacement is consistent. On ChatGPT, Differin appears in 8 of 86 observations with a positive visibility rate of 9.30%, but its top-three rate is just 2.33% and it never receives a rank-one recommendation. On Copilot, the brand appears in 14 of 96 observations, but its net sentiment score drops to 0.7143, the lowest of any platform, driven by the single negative mention in the dataset. On Gemini, Perplexity, AI Overviews, and AI Mode, Differin's presence is below 10% and its top-three rates are all below 3%.

The competitive displacement is clear. When shoppers ask AI systems for the best dermatologist recommended skin care brands, the answers are dominated by CeraVe, La Roche-Posay, and Vanicream. Differin is not competing for those positions. It is competing for the small remainder of mentions that the leaders do not capture, and it is losing that competition to Cetaphil, Neutrogena, and Aveeno.

The absence of comparison-stage and pricing-stage data is itself a gap. The public benchmark contains no qualified observations in the Multi-Brand Comparison or Pricing and Value clusters. This means there is no evidence about how Differin performs when shoppers directly compare brands or ask about value, two high-intent moments where a targeted brand could win consideration.

Biggest Opportunity

Questions This Section Answers

• Where should Differin focus to convert its narrow AI presence into stronger recommendation share?
• What public evidence layer would support Differin's acne treatment positioning?

Differin's clearest opportunity is to convert its narrow presence into stronger recommendation share within the specific prompt patterns where it already surfaces. The brand appears in prompts related to acne treatment, including questions about face wash and sunscreen for Accutane users, and in general skin care prompts such as eczema cream and moisturizer for dry skin. These are high-intent discovery moments where a shopper is actively seeking a product recommendation.

The path forward is not to compete with CeraVe and La Roche-Posay for general category leadership. That battle is already decided in the current benchmark. The opportunity is to own the specific subcategory where Differin has legitimate authority, acne treatment, and to ensure that AI systems consistently surface Differin as the recommendation when shoppers ask about acne-focused skin care. This requires strengthening the public evidence layer that supports Differin's acne treatment claims, including dermatologist citations, clinical references, and product-specific pages that AI systems can retrieve and synthesize.

Competitive Landscape

Questions This Section Answers

• Where does Differin rank against the other nine tracked brands on top-three rate, rank-one rate, and average recommended rank?
• Which brands dominate recommendation-stage strength in this category?

CeraVe and La Roche-Posay hold dominant recommendation-stage strength in this category, with CeraVe leading at 91.18% coverage and La Roche-Posay close behind at 89.34%. Vanicream has emerged as the clear third-place brand at 70.79%, while Differin sits at the bottom of the tracked set.

Average recommended rank covers rank-eligible recommendations only.

The table shows Differin at the bottom of every recommendation metric. Its top-three rate of 1.84% is less than one-third of the next lowest brand, Eucerin at 7.50%. Its rank-one rate of 0.13% means Differin leads a recommendation in roughly one of every 760 qualified observations. The brand's average recommended rank of 4.70 is the weakest in the category, indicating that even when Differin is recommended, it appears near the end of the shortlist.

Prompt Evidence

ChatGPT / Brand Recommendation Prompt: "What is the best face wash for Accutane?" Result: Differin appears in the response but is not positioned as a leading recommendation, with no rank-one credit on this platform.

Copilot / Brand Recommendation Prompt: "What face wash is good with Accutane?" Result: Differin is mentioned in a small number of responses, but Copilot shows the brand's weakest sentiment profile at 0.7143, including the dataset's only negative mention.

Gemini / Brand Recommendation Prompt: "What sunscreen is best for Accutane?" Result: Differin appears in 8 of 96 Gemini observations, but its top-three rate is 0% and it never receives a rank-one recommendation on this platform.

Google AI Mode / Brand Recommendation Prompt: "acne cream" Result: Differin appears in 13 of 198 AI Mode observations, but its positive visibility rate is just 6.06%, the lowest of any platform, and it receives no rank-one recommendations.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompt patterns where Differin appears and identify which high-intent acne treatment questions are producing mentions without recommendation credit.

Phase 2: Recommendation Readiness Plan Prioritize the subcategory where Differin holds legitimate authority, acne treatment, and identify the page, content, and citation gaps that prevent AI systems from recommending the brand more prominently.

Phase 3: Owned Answer Layer Buildout Develop product-specific pages and clinical reference content that directly answer the acne treatment questions where Differin should be the natural recommendation.

Phase 4: Citation / Authority Layer Development Strengthen the dermatologist, clinical, and professional evidence sources that AI systems can retrieve to support Differin's acne treatment positioning.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Differin's presence, recommendation coverage, and placement monthly to measure whether the brand is converting its narrow presence into stronger recommendation positions.

Why This Matters

AI-generated recommendations are becoming the first filter in skin care purchasing decisions. When a shopper asks an AI assistant for the best dermatologist recommended products, the brands that appear in that answer have a structural advantage over brands that do not. Differin is currently on the wrong side of that filter, appearing in fewer than 9% of qualified observations and leading recommendations in fewer than 1%.

Presence alone is not enough. Differin is mentioned positively when it appears, but those mentions rarely convert into a top-three or rank-one recommendation. The next move is not to chase broad category visibility. It is to correct the specific prompt, page, and citation layers that determine whether AI systems recommend Differin when shoppers ask about acne treatment, the moment where the brand has the strongest claim to authority.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Differin, this calculation is (62 × 1 + 5 × 0 + 1 × -1) / 68, producing a net sentiment score of 0.8971.

This score matters because unclassified mention counts are misleading. A brand can appear in hundreds of AI responses and still lose the decision moment if those mentions are neutral references, cautionary notes, or competitor comparisons. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it separates brands that are being recommended from brands that are merely being discussed.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Differin's AI visibility and recommendation performance in the dermatologist recommended skin care brands category, using the LLM Authority Index AI Market Discovery Index as the source of evidence.
2. The reporting window is September 2026, with July 2026 as the baseline for movement analysis.
3. Six AI surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The benchmark began with 800 prompt-surface observations and produced 760 qualified observations after excluding 15 irrelevant prompts and 25 reserved observations.
5. The competitor universe includes 10 tracked brands: Aveeno, CeraVe, Cetaphil, Differin, EltaMD, Eucerin, La Roche-Posay, Neutrogena, SkinCeuticals, and Vanicream.
6. All qualified observations fell into the Brand Recommendation cluster, which captures discovery and consideration-stage questions seeking brand recommendations.
7. Stage 0 extraction captured prompt-level data including query, AI surface, answer, brand outcome, recommendation placement, and sentiment.
8. A mention is defined as any qualified observation where the brand appears in the AI response, regardless of whether it is recommended.
9. A valid recommendation is defined as a qualified observation where the brand appears in a recommendation shortlist with positive framing.
10. Differin operates on a small base, with 60 valid recommendations in September 2026, making percentage movements less stable than for larger brands.
11. The public benchmark does not include qualified observations in the Pricing and Value or Multi-Brand Comparison clusters, so this report cannot assess Differin's performance in those high-intent moments.
12. Month-over-month movement identifies changes worth investigating; it does not by itself establish the cause of those changes.

Get Your AI Visibility Audit

The public benchmark shows where Differin stands in AI-generated recommendations, but it does not explain why the brand is being displaced or which specific prompts are driving its limited presence. A company-level AI visibility audit maps the prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized strategy for converting Differin's narrow presence into stronger recommendation positions.